Amit Etkin

CIK: 0002007795

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)6 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ANRO

Alto Neuroscience, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (12 total)

ANRO
Alto Neuroscience, Inc.
May 14, 2026
Gift(G)
Direct
400K shares-
ANRO
Alto Neuroscience, Inc.
Mar 1, 2026
Tax Payment(F)
Direct
6.2K shares at avg. $19.69$123K
ANRO
Alto Neuroscience, Inc.
Feb 11, 2026
Award(A)
Employee Stock Option (Right to Buy)
Direct
306K shares-
ANRO
Alto Neuroscience, Inc.
Jul 3, 2025
Award(A)
Employee Stock Option (Right to Buy)
Direct
247.3K shares-
ANRO
Alto Neuroscience, Inc.
Jul 3, 2025
Award(A)
Employee Stock Option (Right to Buy)
Direct
223K shares-
ANRO
Alto Neuroscience, Inc.
Jul 3, 2025
Disposition(D)
Employee Stock Option (Right to Buy)
Direct
223K shares-
ANRO
Alto Neuroscience, Inc.
Jul 3, 2025
Award(A)
Employee Stock Option (Right to Buy)
Direct
215K shares-
ANRO
Alto Neuroscience, Inc.
Jul 3, 2025
Disposition(D)
Employee Stock Option (Right to Buy)
Direct
215K shares-
ANRO
Alto Neuroscience, Inc.
Jul 3, 2025
Disposition(D)
Employee Stock Option (Right to Buy)
Direct
247.3K shares-
ANRO
Alto Neuroscience, Inc.
Jul 3, 2025
Award(A)
Employee Stock Option (Right to Buy)
Direct
34.6K shares-
ANRO
Alto Neuroscience, Inc.
Jul 3, 2025
Disposition(D)
Employee Stock Option (Right to Buy)
Direct
34.6K shares-
ANRO
Alto Neuroscience, Inc.
Feb 5, 2025
Award(A)
Employee Stock Option (Right to Buy)
Direct
215K shares-

		Type	Shares	Price		Ownership
May 14, 2026	ANRO Alto Neuroscience, Inc.	Gift(G)	400,000	-	$0	Direct
Mar 1, 2026	ANRO Alto Neuroscience, Inc.	Tax Payment(F)	6,227	$19.69	$122,610	Direct
Feb 11, 2026	ANRO Alto Neuroscience, Inc.	Award(A) Employee Stock Option (Right to Buy)	306,000	-	-	Direct
Jul 3, 2025	ANRO Alto Neuroscience, Inc.	Award(A) Employee Stock Option (Right to Buy)	247,290	-	-	Direct
Jul 3, 2025	ANRO Alto Neuroscience, Inc.	Award(A) Employee Stock Option (Right to Buy)	223,000	-	-	Direct
Jul 3, 2025	ANRO Alto Neuroscience, Inc.	Disposition(D) Employee Stock Option (Right to Buy)	223,000	-	-	Direct
Jul 3, 2025	ANRO Alto Neuroscience, Inc.	Award(A) Employee Stock Option (Right to Buy)	215,000	-	-	Direct
Jul 3, 2025	ANRO Alto Neuroscience, Inc.	Disposition(D) Employee Stock Option (Right to Buy)	215,000	-	-	Direct
Jul 3, 2025	ANRO Alto Neuroscience, Inc.	Disposition(D) Employee Stock Option (Right to Buy)	247,290	-	-	Direct
Jul 3, 2025	ANRO Alto Neuroscience, Inc.	Award(A) Employee Stock Option (Right to Buy)	34,620	-	-	Direct
Jul 3, 2025	ANRO Alto Neuroscience, Inc.	Disposition(D) Employee Stock Option (Right to Buy)	34,620	-	-	Direct
Feb 5, 2025	ANRO Alto Neuroscience, Inc.	Award(A) Employee Stock Option (Right to Buy)	215,000	-	-	Direct

1-12 of 12 transactions

About Etkin Amit

Etkin Amit (SEC CIK 0002007795) files insider reports with the SEC as PRESIDENT AND CEO of Alto Neuroscience, Inc. (ANRO).

Signal8 holds 5 ownership filings by Etkin Amit, all Form 4s, filed between Feb 7, 2025 and May 15, 2026. Those filings report 12 transactions, from Feb 5, 2025 to May 14, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Etkin Amit's filings is in MOUTAIN VIEW, CA.

Recent filings by Etkin Amit

May 14, 2026: Gift of ANRO shares (Form 4, code G).
Mar 1, 2026: Tax withholding of ANRO shares (Form 4, code F).
Feb 11, 2026: Grant or award of ANRO derivative securities (Form 4, code A).
Jul 3, 2025: Grants or awards of ANRO derivative securities (2 lines, Form 4, code A).
Jul 3, 2025: Disposition to issuer transaction of ANRO derivative securities (Form 4, code D).

Other insiders filing for Alto Neuroscience, Inc. (ANRO)

Smith Nicholas Conrad, PRESIDENT AND CFO
Miller Andrew Craig, Director
Sanchez Ramiro, Director
Cox Christopher Nixon, Director
Manji Husseini, Director
Dreyfus Andrew, Director

How to read Form 4 transaction codes